Antria Overview
- Founded
- 2010
- Status
- Private
- Latest Deal Type
- Angel
- (Cancelled)
Antria General Information
Description
Operator of a clinical research organization. The company focuses on the discovery and development of new products and treatments with stem cells derived from adult patients' own fat cells, known as autologous derived stem cells to help patients with various chronic and acute medical conditions.
Contact Information
Primary Industry
Therapeutic Devices
Other Industries
Drug Discovery
Biotechnology
Primary Office
- 841 Hospital Road
- Suite 2400
- Indiana, PA 15701
- United States
+1 (724) 000-0000
Antria Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Angel (individual) | 30-Jul-2015 | Cancelled | Startup | |||
| 1. Angel (individual) | 24-Jan-2013 | 00.000 | 00.000 | Completed | Startup |
Antria Executive Team (5)
Antria Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| David Bizousky MD | Antria | Medical Monitor & Board Member | 000 0000 |
| Leonard Maliver MD | Antria | Chief Executive Officer & Board Member | 000 0000 |
| Shah Rahimian MD | Antria | President, Research & Development & Board Member | 000 0000 |
| Sharon Barto | Antria | Vice President, Business Development & Board Member | 000 0000 |